(Q40300226)

English

Comorbidities, bone-sparing agent prescription history and their determinants among postmenopausal women in UK primary care settings: a retrospective database study

scientific article published on 19 November 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Comorbidities, bone-sparing agent prescription history and their determinants among postmenopausal women in UK primary care settings: a retrospective database study (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

author name string

M Feudjo-Tepie

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

S Ferguson

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

A Roddam

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

A Taylor

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

J Bayly

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

C Critchlow

6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

language of work or name

0 references

publication date

19 November 2015

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Archives of Osteoporosis

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

https://scigraph.springernature.com/pub.10.1007/s11657-015-0233-4

0 references

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

1 reference

https://api.crossref.org/works/10.1007%2FS11657-015-0233-4

21 January 2018

A systematic review of persistence and compliance with bisphosphonates for osteoporosis

1 reference

https://api.crossref.org/works/10.1007%2FS11657-015-0233-4

21 January 2018

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

https://api.crossref.org/works/10.1007%2FS11657-015-0233-4

21 January 2018

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS11657-015-0233-4

21 January 2018

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

1 reference

https://api.crossref.org/works/10.1007%2FS11657-015-0233-4

21 January 2018

Risedronate prevents bone loss in early postmenopausal women: a prospective randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1007%2FS11657-015-0233-4

21 January 2018

The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1007%2FS11657-015-0233-4

21 January 2018

Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1007%2FS11657-015-0233-4

21 January 2018

Compliance with drug therapies for the treatment and prevention of osteoporosis

1 reference

https://api.crossref.org/works/10.1007%2FS11657-015-0233-4

21 January 2018

Adherence and profile of non-persistence in patients treated for osteoporosis--a large-scale, long-term retrospective study in The Netherlands

1 reference

https://api.crossref.org/works/10.1007%2FS11657-015-0233-4

21 January 2018

GRAND: the German retrospective cohort analysis on compliance and persistence and the associated risk of fractures in osteoporotic women treated with oral bisphosphonates

1 reference

https://api.crossref.org/works/10.1007%2FS11657-015-0233-4

21 January 2018

Pattern of intravenous bisphosphonate use in outpatient care in Germany.

1 reference

https://api.crossref.org/works/10.1007%2FS11657-015-0233-4

21 January 2018

Adoption of once-monthly oral bisphosphonates and the impact on adherence

1 reference

https://api.crossref.org/works/10.1007%2FS11657-015-0233-4

21 January 2018

Longitudinal change in clinical fracture incidence after initiation of bisphosphonates

1 reference

https://api.crossref.org/works/10.1007%2FS11657-015-0233-4

21 January 2018

Use of the UK General Practice Research Database for pharmacoepidemiology

1 reference

https://api.crossref.org/works/10.1007%2FS11657-015-0233-4

21 January 2018

Fracture outcomes related to persistence and compliance with oral bisphosphonates

1 reference

https://api.crossref.org/works/10.1007%2FS11657-015-0233-4

21 January 2018

The potential effects on fracture outcomes of improvements in persistence and compliance with bisphosphonates.

1 reference

https://api.crossref.org/works/10.1007%2FS11657-015-0233-4

21 January 2018

COPD and osteoporosis

1 reference

https://api.crossref.org/works/10.1007%2FS11657-015-0233-4

21 January 2018

Discontinuation and reinitiation patterns of osteoporosis treatment among commercially insured postmenopausal women

1 reference

https://api.crossref.org/works/10.1007%2FS11657-015-0233-4

21 January 2018

Determinants of adherence to osteoporosis treatment in clinical practice

1 reference

https://api.crossref.org/works/10.1007%2FS11657-015-0233-4

21 January 2018

Persistence with weekly alendronate therapy among postmenopausal women

1 reference

https://api.crossref.org/works/10.1007%2FS11657-015-0233-4

21 January 2018

Compliance with osteoporosis medications

1 reference

https://api.crossref.org/works/10.1007%2FS11657-015-0233-4

21 January 2018

Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW)

1 reference

https://api.crossref.org/works/10.1007%2FS11657-015-0233-4

21 January 2018

Fracture risk in CKD.

1 reference

https://api.crossref.org/works/10.1007%2FS11657-015-0233-4

21 January 2018

Accuracy of diagnosis of psychosis on general practice computer system

1 reference

https://api.crossref.org/works/10.1007%2FS11657-015-0233-4

21 January 2018

Osteoporosis management: a perspective based on bisphosphonate data from randomised clinical trials and observational databases

1 reference

https://api.crossref.org/works/10.1007%2FS11657-015-0233-4

21 January 2018

Validation of general practitioner-diagnosed COPD in the UK General Practice Research Database

1 reference

https://api.crossref.org/works/10.1007%2FS11657-015-0233-4

21 January 2018

Switch patterns of osteoporosis medication and its impact on persistence among postmenopausal women in the UK General Practice Research Database

1 reference

https://api.crossref.org/works/10.1007%2FS11657-015-0233-4

21 January 2018

Identifiers

10.1007/S11657-015-0233-4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40300226&oldid=1894200105"